The Lancet HIV-logo

The Lancet HIV

Science Podcasts

Peter Hayward, Editor-in-Chief of The Lancet HIV, and Philippa Harris, Deputy Editor, speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Peter Hayward, Editor-in-Chief of The Lancet HIV, and Philippa Harris, Deputy Editor, speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Location:

United States

Description:

Peter Hayward, Editor-in-Chief of The Lancet HIV, and Philippa Harris, Deputy Editor, speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Language:

English


Episodes

In Conversation With... Chloe Orkin

3/29/2021
Professor Chloe Orkin (Queen Mary University London, UK) joins Peter Hayward to talk about long-acting cabotegravir for HIV treatment and the 96 weeks of the FLAIR study.

Duration:00:14:59

In Conversation With... Sarah Calabrese

3/1/2021
Sarah Calabrese (George Washington University, USA) talks to Deputy Editor Philippa Harris about prioritising sexual pleasure and correcting misinformation in the era of U=U.

Duration:00:16:16

In Conversation With… Le Minh Giang and Todd Korthuis

2/1/2021
Le Minh Giang (Hanoi Medical University, Vietnam) and Todd Korthuis (Oregon Health and Science University, USA) discuss their work in Vietnam on treating opioid use disorder in people with HIV with Deputy Editor Philippa Harris.

Duration:00:14:00

In Conversation With…Michael Herce, Tonia Poteat, Ward van Bilsen and Hanne Zimmerman, and Jade Pagkas-Bather

12/8/2020
In a bumper edition, we talk to contributors to several papers in the December issue on diverse topics that include test-and-treat in correctional facilities, PrEP engagement in transgender women, the burden of living with HIV in MSM, and gentrification in San Francisco.

Duration:00:52:30

In Conversation With… Mathebe Kopo and Alain Amstutz

10/28/2020
Deputy Editor Philippa Harris discusses HIV testing and the HOSENG trial with researchers Mathebe Kopo (SolidarMed, Lesotho) and Alain Amstutz (Swiss Tropical and Public Health Institute, Basel, Switzerland).

Duration:00:26:54

In Conversation With…Susannah Mayhew

9/30/2020
Susannah Mayhew (London School of Hygiene and Tropical Medicine) joins Deputy Editor Philippa Harris to discuss integration of sexual and reproductive health and HIV services.

Duration:00:12:39

In Conversation With…Ankur Gupta-Wright and Melanie Alufandika-Moyo

9/4/2020
Editor-in-Chief, Peter Hayward, talks to researchers from London School of Hygiene and Tropical Medicine and Melanie Alufandika-Moyo Malawi-Liverpool Wellcome Trust about their research on virological failure and HIV drug resistance in patients with HIV in hospital in Malawi.

Duration:00:14:11

In Conversation With... Di Gibb and Anna Turkova

8/4/2020
Researchers from the Medical Research Council Clinical Trials Unit at University College London join Editor-in-Chief Peter Hayward to discuss paediatric HIV treatment and the pharmacokinetic substudy of the ODYSSEY trial of dolutegravir for children with HIV.

Duration:00:21:21

In Conversation With... Chi-Chi Udeagu

7/1/2020
Deputy Editor Philippa Harris talks to Chi-Chi Udeagu (New York City Department of Health and Mental Hygiene, USA) about HIV partner services in New York City and the impact of COVID-19.

Duration:00:23:58

In Conversation With... Kelly Dooley and Gavin Churchyard

6/3/2020
Kelly Dooley (Johns Hopkins University, USA) and Gavin Churchyard (Aurum Institute, South Africa) discuss their trial on tuberculosis prevention in people with HIV taking dolutegravir-based antiretroviral therapy with Deputy Editor Philippa Harris.

Duration:00:14:26

In Conversation With... The London Patient

5/4/2020
Adam Castillejo joins The Lancet HIV’s Editor, Peter Hayward, to talk about his experience of HIV, cancer, and becoming the second person to be cured of HIV.

Duration:00:36:10

Point-of-care viral load testing

4/1/2020
Deputy Editor Philippa Harris discusses viral load testing with Paul Drain (University of Washington, USA) and a trial of point-of-care testing with task shifting to improve treatment outcomes.

Duration:00:10:16

HIV transmission dynamics in Rakai, Uganda

3/4/2020
Joseph Kagaayi (Rakai Health Sciences Program, Uganda) and Oliver Ratman (Imperial College London, UK) talk to Editor-in-Chief Peter Hayward about the world famous research site and the insights that deep sequencing has provided into the flow of HIV in their latest research.

Duration:00:26:00

HIV and influenza vaccine

2/12/2020
Marta Nunes (University of the Witwatersrand, Johannesburg, South Africa) talks to Philippa Harris about vaccination response in people living with HIV and a trial of influenza vaccine dosing in pregnant women with HIV in South Africa.

Duration:00:11:00

Living well with HIV

12/4/2019
For World AIDS day, The Lancet HIV Deputy Editor Philippa Harris talks to Jeff Lazarus and Nikos Dedes about the importance of good health-related quality of life and the barriers people living with HIV face in achieving this.

Duration:00:18:36

HIV vaccines

10/29/2019
Giuseppe Pantaleo (Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Switzerland) tells Peter Hayward about a phase 1 vaccine study published in the November issue of The Lancet HIV, and gives an overview of the HIV vaccine field.

Duration:00:23:45

Risk prediction and prevention

9/30/2019
Julia Marcus and Douglas Krakower talk to Peter Hayward about the use of electronic health record data to predict HIV risk and identify PrEP candidates.

Duration:00:17:48

Third-line therapy

9/4/2019
The Lancet HIV Editor Peter Hayward talks to Beatriz Grinsztejn (Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Brazil) about ACTG A5288, an international, multiarm trial investigating management of second-line treatment failure

Duration:00:13:21

Assessing the safety of a PrEP intravaginal ring

7/30/2019
The Lancet HIV Deputy Editor Philippa Harris talks to Betsy Herold (Albert Einstein College of Medicine, USA) about her trial investigating a tenofovir disoproxil fumarate intravaginal ring for pre-exposure prophylaxis in sexually active women.

Duration:00:17:21

Safer conception for couples living with HIV

7/2/2019
Sheree Schwartz (Johns Hopkins School of Public Health) talks to The Lancet HIV Editor-in-Chief Peter Hayward about the Sakh'umndeni Safer Conception Project safer conception project for South African couples living with HIV.

Duration:00:24:18